Bexarotene combined with lapatinib for the treatment of Cushing’s disease: evidence based on drug repositioning and experimental confirmation

Detalles Bibliográficos
Autores principales: Yu, Haoying, Ren, Shuyue, Wang, Jingrong, Lv, Tingting, Sun, Lan, Du, Guanhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7456421/
https://www.ncbi.nlm.nih.gov/pubmed/32862196
http://dx.doi.org/10.1038/s41392-020-00284-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7456421/
https://www.ncbi.nlm.nih.gov/pubmed/32862196
http://dx.doi.org/10.1038/s41392-020-00284-7

Ejemplares similares